Chief Executive Officer
Cyrus K. Mirsaidi is the Chief Executive Officer of Molecular Response with 20 years of senior management experience in strategic planning, business development, and licensing. Mr. Mirsaidi brings both practical and strategic senior management experience in drug discovery, biomarker development, and clinical diagnostics and has proven himself a capable leader who can build and motivate teams to achieve great results. He held several senior level management positions in his ten-year career at Nichols Institute Diagnostics (a division of Quest Diagnostics), where he was responsible for global launch of clinical diagnostic IVD tests on automated platforms and development of new strategies for application of routine immunoassay tests to more profitable ‘Point of Care’ markets. As general manager and executive director at Ontogen, a small molecule discovery company, he managed operations of a subsidiary focused on high throughput synthesis and purification of novel compounds. Most recently, Mr. Mirsaidi served as Vice President at AltheaDx, a San Diego biotechnology company, where he led the business development and licensing efforts with pharmaceutical partners. Mr. Mirsaidi received a B.S. in Biology from the University of California, Irvine. He currently resides in San Diego.